EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieMultizentrische StudieOpen Access · CC BY-NC 4.0

The Comparison Between Low‐ and High‐Concentration Injection Solution Ability for Colorectal Endoscopic Submucosal Dissection

Naohisa Yoshida iD, Ryohei Hirose iD, Yoshikazu Inagaki iD, Takaaki Murakami, Yutaka Inada, Daisuke Hasegawa, Yuri Tomita, Reo Kobayashi iD, Osamu Dohi iD, Ken Inoue iD, Yoshito Itoh, Naoyuki Yamaguchi

Journal of Gastroenterology and Hepatology · 2025

DOI: 10.1111/jgh.16943 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Naohisa Yoshida und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Colorectal Neoplasms, Alginates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Injection solution is important for achieving submucosal elevation in endoscopic submucosal dissection (ESD) and various viscous solutions categorized as low‐concentration injection solution (LCS) or high‐concentration injection solution (HCS) are used. We analyzed the difference between LCS and HCS in colorectal ESD.

Methods

This was a prospective, randomized controlled trial at six Japanese institutions. Patients with early neoplastic lesions of ≥ 20 mm were enrolled from March 2022 to September 2023. Sodium alginate (Liftal K, Kaigen Pharma Co., Osaka, Japan) was used as the injection solution, and the concentration of HCS and LCS was set at 0.6% and 0.3%, respectively. Participants were randomized to HCS or LCS groups and the primary endpoint was the noninferiority about ESD procedure time of LCS compared to HCS.

Results

The LCS and HCS groups consisted of 79 and 82 cases, respectively. The ESD procedure time (min, mean ± standard deviation) was significantly noninferior between the LCS and HCS groups ( p < 0.001) and was significantly shorter in the LCS group than in the HCS group (61.9 ± 39.2 vs. 76.9 ± 67.5, p = 0.044). There were no significant differences in en bloc resection (98.7% vs. 100.0%, p = 0.985), perioperative perforation (2.5% vs. 2.4%, p = 0.639), and delayed bleeding (1.3% vs. 1.2%, p = 0.493). In the subgroup analysis, the ESD procedure times were significant for lesions of ≥ 40 mm (74.3 ± 30.4 vs. 125.3 ± 107.2, p = 0.031) and experts (51.5 ± 29.2 vs. 69.4 ± 58.9, p = 0.046). Additionally, injection volumes (mL) were not significant (38.0 ± 20.2 vs. 33.0 ± 27.0, p = 0.098) in the two groups.

Conclusion

LCS was noninferior to HCS in terms of procedure time and significantly reduced it. Trial Registration University Hospital Medical Information Network Clinical Trials Registry number: UMIN000048661.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoscopic Mucosal ResectionColorectal NeoplasmsAlginatesHumansMaleFemaleAgedProspective StudiesMiddle AgedOperative TimeInjectionsJapanTreatment Outcome

Stichwörter der Autor:innen

adenomacolorectal lesionsendoscopic submucosal dissectioninjection solutionsodium alginate

Substanzen

Alginates

Autor:innen und Institutionen

  • Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Infectious Diseases, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Gastroenterology, Nishijin Hospital, Kyoto, Japan.
  • Department of Gastroenterology, Aiseikai Yamashina Hospital, Kyoto, Japan.
  • Department of Gastroenterology, Kyoto First Red Cross Hospital, Kyoto, Japan.
  • Department of Gastroenterology, Ayabe City Hospital, Kyoto, Japan.

ORCID-Profile: Naohisa Yoshida, Ryohei Hirose, Yoshikazu Inagaki, Reo Kobayashi, Osamu Dohi, Ken Inoue

Zitieren

APA

Yoshida, N., Hirose, R., Inagaki, Y., Murakami, T., Inada, Y., Hasegawa, D., Tomita, Y., Kobayashi, R., Dohi, O., Inoue, K., Itoh, Y., & Yamaguchi, N. (2025). The Comparison Between Low‐ and High‐Concentration Injection Solution Ability for Colorectal Endoscopic Submucosal Dissection. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16943

Vancouver

Yoshida N, Hirose R, Inagaki Y, Murakami T, Inada Y, Hasegawa D, et al. The Comparison Between Low‐ and High‐Concentration Injection Solution Ability for Colorectal Endoscopic Submucosal Dissection. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16943

BibTeX
@article{Yoshida2025,
  author = {Yoshida, Naohisa and Hirose, Ryohei and Inagaki, Yoshikazu and Murakami, Takaaki and Inada, Yutaka and Hasegawa, Daisuke and Tomita, Yuri and Kobayashi, Reo and Dohi, Osamu and Inoue, Ken and Itoh, Yoshito and Yamaguchi, Naoyuki},
  title = {The Comparison Between Low‐ and High‐Concentration Injection Solution Ability for Colorectal Endoscopic Submucosal Dissection},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1111/jgh.16943}
}
Kostenlos starten →